# Potential Efficacy of Polyphenols and Isothiocyanates in the Management of Genitourinary Diseases: A Systematic Review of Preclinical and Clinical Studies

**Authors:** Eugenia Piragine, Pasquale Moretti, Salvatore Scarpulla, Vincenzo Calderone, Alma Martelli

PMC · DOI: 10.3390/ijms27041660 · 2026-02-08

## TL;DR

This paper reviews how plant compounds like polyphenols and isothiocyanates may help manage genitourinary diseases, based on preclinical and clinical studies.

## Contribution

The study provides the first systematic review of polyphenols and isothiocyanates for genitourinary diseases, highlighting gaps in isothiocyanate research.

## Key findings

- Polyphenols show potential benefits in managing various genitourinary conditions like lithiasis and cystitis.
- Few studies on isothiocyanates exist, with inconsistent results.
- More high-quality research is needed to confirm polyphenol efficacy and explore isothiocyanate effects.

## Abstract

The global burden of genitourinary diseases is increasing worldwide, highlighting the need to identify new approaches for their prevention and treatment. In this context, polyphenols, isothiocyanates derived from plants of the Brassicaceae and Moringaceae botanical families, along with their natural sources, represent promising strategies, as they exhibit several health-promoting properties, including antioxidant, anti-inflammatory, and anti-fibrotic effects. However, a comprehensive overview of their benefits in the genitourinary system is currently unavailable. In this paper, we performed a systematic review of the literature by searching two scientific databases (MEDLINE and Scopus). A total of 27 preclinical studies and 16 clinical studies were included. Many studies have investigated the efficacy of isolated polyphenols in animal models of genitourinary diseases, as well as extracts or foods typically rich in polyphenols in humans, demonstrating potential benefits in the management of lithiasis, hyperoxaluria, prostatitis, benign prostatic hyperplasia, glomerulonephritis, vaginal dysbiosis, vaginosis, cystitis, and urinary tract infections. In contrast, few studies have examined isolated isothiocyanates, probably because their pharmacological role has only recently been recognized, and the results have been inconsistent. Further high-quality research is needed to confirm the preliminary evidence on polyphenols and to clarify the biological effects of isothiocyanates and their natural sources in this field.

## Linked entities

- **Diseases:** prostatitis (MONDO:0005280), benign prostatic hyperplasia (MONDO:0010811), glomerulonephritis (MONDO:0002462), cystitis (MONDO:0006032)

## Full-text entities

- **Genes:** ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, PON1 (paraoxonase 1) [NCBI Gene 5444] {aka ESA, MVCD5, PON}, KLK3 (kallikrein related peptidase 3) [NCBI Gene 354] {aka APS, KLK2A1, PSA, hK3}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, MPO (myeloperoxidase) [NCBI Gene 4353], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, Il18 (interleukin 18) [NCBI Gene 29197] {aka IL-1 gamma, IL-18}, GCLC (glutamate-cysteine ligase catalytic subunit) [NCBI Gene 2729] {aka CNSHA7, GCL, GCS, GLCL, GLCLC}, Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, GCLM (glutamate-cysteine ligase modifier subunit) [NCBI Gene 2730] {aka GLCLR}, Nfkb1 (nuclear factor kappa B subunit 1) [NCBI Gene 81736] {aka EBP-1, NF-kB, NFKB-p50, p50}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Ar (androgen receptor) [NCBI Gene 24208] {aka Andr, Tfm}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728] {aka DHQU, DIA4, DTD, NMOR1, NMORI, QR1}, GSR (glutathione-disulfide reductase) [NCBI Gene 2936] {aka CNSHA10, GR, GSRD, HEL-75, HEL-S-122m}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Sirt1 (sirtuin 1) [NCBI Gene 309757] {aka Sir2}
- **Diseases:** Chronic Prostatitis (MESH:D011472), chronic (MESH:D002908), urinary incontinence (MESH:D014549), Genitourinary Diseases (MESH:D000091642), hyperplasia (MESH:D006965), erythema (MESH:D004890), pathological (MESH:D005598), vaginal (MESH:D014627), vaginal discharge (MESH:D019522), dryness (MESH:D014987), type 2 diabetes (MESH:D003924), glomerular damage (MESH:D007674), UTIs (MESH:D014552), vulvovaginal candidiasis (MESH:D002181), CaOx kidney stones (MESH:D007669), Nephro-/Urolithiasis (MESH:D052878), nephropathic (MESH:D003554), BPH (MESH:D011470), cardiovascular and metabolic diseases (MESH:D002318), infections (MESH:D007239), dyspareunia (MESH:D004414), gastrointestinal disorders (MESH:D005767), hypertension (MESH:D006973), Glomerulonephritis (MESH:D005921), albuminuria (MESH:D000419), hyperoxaluria (MESH:D006959), genitourinary cancers (MESH:D014565), itching (MESH:D011537), stone formation (MESH:D058426), metabolic (MESH:D008659), neurological disorders (MESH:D009461), Cystitis (MESH:D003556), proteinuria (MESH:D011507), bladder bleeding (MESH:D001745), tubulointerstitial injury (MESH:D009395), microbial infections (MESH:D015163), lithiasis (MESH:D020347), organ dysfunction (MESH:D009102), edema (MESH:D004487), overactive bladder symptoms (MESH:D053201), cancer (MESH:D009369), Vaginal Dysbiosis (MESH:D064806), diabetes (MESH:D003920), Vaginosis (MESH:D016585), pain (MESH:D010146), inflammation (MESH:D007249), genitourinary pathological conditions (MESH:D020763), injury to (MESH:D014947), cardiometabolic diseases (MESH:D024821), malodor (MESH:C536561), nephrolithiasis (MESH:D053040), fibrosis (MESH:D005355)
- **Chemicals:** magnesium (MESH:D008274), flavonoids (MESH:D005419), creatinine (MESH:D003404), ROS (MESH:D017382), calcium (MESH:D002118), phenethyl ITC (MESH:C058305), epigallocatechin (MESH:C057580), caffeic acid (MESH:C040048), TBARS (MESH:D017392), ellagic acid (MESH:D004610), lipid (MESH:D008055), Tea Tree Oil (MESH:D020947), dehydroepiandrosterone (MESH:D003687), naringenin (MESH:C005273), nystatin (MESH:D009761), oligonol (MESH:C514283), protocatechuic acid (MESH:C009091), Polyphenol (MESH:D059808), glycol (MESH:D006018), steroid hormones (MESH:D013256), citrate (MESH:D019343), GSH (MESH:D005978), piperine (MESH:C008922), MDA (MESH:D008315), thiols (MESH:D013438), trimethoprim (MESH:D014295), urea (MESH:D014508), 8-isoprostane (MESH:C075750), potassium (MESH:D011188), sodium (MESH:D012964), H2O2 (MESH:D006861), AZO (-), H2S (MESH:D006862), bergamot (MESH:C068336), sulfur (MESH:D013455), curcumin (MESH:D003474), pyrogallic acid (MESH:D011748), NO (MESH:D009569), 8-OHdG (MESH:D000080242), chloride (MESH:D002712), hydroxytyrosol (MESH:C005975), resveratrol (MESH:D000077185), GLs (MESH:D005961), ITCs (MESH:D017879), testosterone (MESH:D013739), hydroxybenzoic acid (MESH:C017616), CaOx (MESH:D002129), prostaglandin E2 (MESH:D015232), epicatechin (MESH:D002392), Pterostilbene (MESH:C107773), stilbene (MESH:D013267), wax (MESH:D014885), sulforaphane (MESH:C016766), rutin (MESH:D012431), metronidazole (MESH:D008795), ethylene glycol (MESH:D019855), oxalate (MESH:D010070), dehydroepiandrosterone-sulphate (MESH:D019314), quercetin (MESH:D011794), androstenedione (MESH:D000735)
- **Species:** Allium cepa (onion, species) [taxon 4679], PX clade (clade) [taxon 569578], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Camellia sinensis (black tea, species) [taxon 4442], Brassica oleracea var. italica (asparagus broccoli, varietas) [taxon 36774], Rodentia (rodent, order) [taxon 9989], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Vaccinium macrocarpon (American cranberry, species) [taxon 13750], Solanum lycopersicum (tomato, species) [taxon 4081], Streptococcus (genus) [taxon 1301], Actinomycetota (actinobacteria, phylum) [taxon 201174], Vitis vinifera (wine grape, species) [taxon 29760], Tetragonula sp. (species) [taxon 2942419], Brassica oleracea (wild cabbage, species) [taxon 3712], Serenoa repens (saw palmetto, species) [taxon 4722], Eruca vesicaria subsp. sativa (arugula, subspecies) [taxon 29727], Lactobacillus (genus) [taxon 1578], Mus musculus (house mouse, species) [taxon 10090], Malus domestica (apple, species) [taxon 3750], Escherichia coli (E. coli, species) [taxon 562], Candida albicans (species) [taxon 5476], Castanea sativa (European chestnut, species) [taxon 21020]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940174/full.md

---
Source: https://tomesphere.com/paper/PMC12940174